.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Cerilliant
Dow
Johnson and Johnson
Teva
Argus Health
Chubb
Novartis
UBS

Generated: January 21, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 10151239

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Boehringer IngelheimPRADAXAdabigatran etexilate mesylateCAPSULE;ORAL022512-001Oct 19, 2010RXYesNo➤ Subscribe➤ SubscribeMETHOD OF REVERSING THE ANTICOAGULANT EFFECT OF DABIGATRAN USING IDARUCIZUMAB
Boehringer IngelheimPRADAXAdabigatran etexilate mesylateCAPSULE;ORAL022512-002Oct 19, 2010RXYesYes➤ Subscribe➤ SubscribeMETHOD OF REVERSING THE ANTICOAGULANT EFFECT OF DABIGATRAN USING IDARUCIZUMAB
Boehringer IngelheimPRADAXAdabigatran etexilate mesylateCAPSULE;ORAL022512-003Nov 20, 2015RXYesNo➤ Subscribe➤ SubscribeMETHOD OF REVERSING THE ANTICOAGULANT EFFECT OF DABIGATRAN USING IDARUCIZUMAB
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist